Cell3 Direct

Non-invasive fetal Rhesus D blood genotyping

By nonacus-developer / June 11, 2021 / Comments Off on Non-invasive fetal Rhesus D blood genotyping

June 14, 2021 Reducing the need for prophylactic anti-D treatment for pregnant women. Non-invasive prenatal testing (NIPT) using cell-free fetal DNA in maternal plasma is being used to determine fetal RhD blood group antigen status so that RhD-negative pregnant women can avoid receiving antenatal anti-D if they are carrying a RhD-negative baby. The Rhesus D…

Read More